A rare case of small bowel intussusception A 58-year-old man was referred to our institution with a 2-month history of worsening colicky upper abdominal pain associated with eating and relieved by vomiting, and weight loss. Gastroscopy revealed grade B reflux esophagitis, erosive gastritis, and duodenitis. A Campylobacter-like organism (CLO) test was negative for Helicobacter pylori, and duodenal biopsies were normal. Empirical triple therapy with amoxicillin, clarithromycin, and omeprazole was administered. An abdominal ultrasound was normal. A barium followthrough showed an unusual jejunal appearance with dilatation also noted (• " Fig. 1 ). Subsequent CT enterography suggested proximal jejunal tethering. Double-balloon enteroscopy (DBE) revealed, 10 cm beyond the ligament of Treitz, a large sessile, ulcerated 3 -4 cm lesion, hemicircumferentially involving the small bowel wall (• " Fig. 2 ). Multiple biopsies were taken and a tattoo was placed proximal to the lesion. Histopathological analysis showed a dense lymphoid infiltrate including aggregates/germinal centers with perivascular activity, highly suggestive of lymphoma. Immunohistochemistry confirmed low grade B-cell mucosa-associated lymphoid tissue (MALT lymphoma). At 2 weeks after a first cycle with R-CVP (rituximab, cyclophosphamide, vincristine, prednisolone), the patient presented with severe abdominal pain. A computed tomography (CT) scan revealed jejunal intussusception (• " Fig. 3 ), but surgical review recommended conservative management. A second DBE showed no change in the lesion (• " Video 1) after three further cycles of R-CVP. For this rea-son, the patient's chemotherapy was changed to a more aggressive scheme with R-CHOP (rituximab, cyclophosphamide, hydroxydaunorubicin, oncovin, and prednisone) for a further three cycles, and a third DBE revealed a marked improvement with significant regression of the mass (• " Fig. 4,• 
Video 1
Double-balloon enteroscopy (DBE) showed no change in the lesion after four cycles of R-CVP (rituximab, cyclophosphamide, vincristine, prednisolone). 
Video 2
After three cycles of R-CHOP (rituximab, cyclophosphamide, hydroxydaunorubicin, oncovin, and prednisone), double-balloon enteroscopy (DBE) revealed a marked improvement with significant regression of the mass.
